DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Perez EA, Romond EH, Suman VJ. et al.
Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.
J Clin Oncol 2014;
32: 3744-3752
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.